Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Castellano

Showing results (51-60 of 266) with videos related to

Pageof 27
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 10, 2013
Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)Daniel Castellano, Jaume Capdevila, Javier Sastre, et al.
Oncology (Williston Park, N.Y.)|August 14, 2020
Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 PandemicLucil Carril-Ajuria, Yuly A Remolina-Bonilla, Alberto Carretero-Gonzalez, et al.
Archivos Espanoles De Urologia|February 10, 2012
[Hormonal treatment in biochemical recurrence after radical prostatectomy]Alfredo Rodríguez Antolín, José Manuel Duarte Ojeda, Javier Romero Otero, et al.
Molecular Genetics & Genomic Medicine|November 20, 2019
Monoamino oxidase alleles correlate with the presence of essential hypertension among hypogonadic patientsJosé Luis Royo, Daniel Castellano-Castillo, Maximiliano Ruiz-Galdon, et al.
Oncotarget|March 2, 2018
Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trialsAlberto Carretero-González, David Lora, Ismael Ghanem, et al.
Metabolism: Clinical and Experimental|May 20, 2017
Neovascular deterioration, impaired NADPH oxidase and inflammatory cytokine expression in adipose-derived multipotent cells from subjects with metabolic syndromeWilfredo Oliva-Olivera, Said Lhamyani, Leticia Coín-Aragüez, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2009
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of metastatic renal cancerJoaquim Bellmunt, Emiliano Calvo, Daniel Castellano, et al.
BMC Cancer|October 25, 2014
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practiceDaniel Castellano, Javier Puente, Guillermo de Velasco, et al.
Genes|August 15, 2018
Complement Factor C3 Methylation and mRNA Expression Is Associated to BMI and Insulin Resistance in ObesityDaniel Castellano-Castillo, Isabel Moreno-Indias, Jose Carlos Fernandez-Garcia, et al.
Cancers|July 26, 2020
The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical TrialsAlberto Carretero-González, David Lora, Isabel Martín Sobrino, et al.
Pageof 27

Showing results (51-60 of 266) with videos related to

Sort By:
Pageof 27
European Journal of Cancer (Oxford, England : 1990)|September 10, 2013
Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: a phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)Daniel Castellano, Jaume Capdevila, Javier Sastre, et al.
Oncology (Williston Park, N.Y.)|August 14, 2020
Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 PandemicLucil Carril-Ajuria, Yuly A Remolina-Bonilla, Alberto Carretero-Gonzalez, et al.
Archivos Espanoles De Urologia|February 10, 2012
[Hormonal treatment in biochemical recurrence after radical prostatectomy]Alfredo Rodríguez Antolín, José Manuel Duarte Ojeda, Javier Romero Otero, et al.
Molecular Genetics & Genomic Medicine|November 20, 2019
Monoamino oxidase alleles correlate with the presence of essential hypertension among hypogonadic patientsJosé Luis Royo, Daniel Castellano-Castillo, Maximiliano Ruiz-Galdon, et al.
Oncotarget|March 2, 2018
Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trialsAlberto Carretero-González, David Lora, Ismael Ghanem, et al.
Metabolism: Clinical and Experimental|May 20, 2017
Neovascular deterioration, impaired NADPH oxidase and inflammatory cytokine expression in adipose-derived multipotent cells from subjects with metabolic syndromeWilfredo Oliva-Olivera, Said Lhamyani, Leticia Coín-Aragüez, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2009
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of metastatic renal cancerJoaquim Bellmunt, Emiliano Calvo, Daniel Castellano, et al.
BMC Cancer|October 25, 2014
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practiceDaniel Castellano, Javier Puente, Guillermo de Velasco, et al.
Genes|August 15, 2018
Complement Factor C3 Methylation and mRNA Expression Is Associated to BMI and Insulin Resistance in ObesityDaniel Castellano-Castillo, Isabel Moreno-Indias, Jose Carlos Fernandez-Garcia, et al.
Cancers|July 26, 2020
The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical TrialsAlberto Carretero-González, David Lora, Isabel Martín Sobrino, et al.
Pageof 27